Unnamed: 0,title,date,stock,sentiment
1218577.0,Bio-Techne Highlights Portfolio Of SARS-CoV-2 And COVID-19 Research And Therapeutic Development,2020-06-09 07:08:00-04:00,TECH,neutral
1218578.0,"Benzinga's Top Upgrades, Downgrades For May 27, 2020",2020-05-27 09:35:00-04:00,TECH,positive
1218579.0,"Stifel Downgrades Bio-Techne to Hold, Raises Price Target of $260",2020-05-27 06:22:00-04:00,TECH,neutral
1218580.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,TECH,neutral
1218581.0,"Bio-Techne Reports Partnership With Kantaro For Development, Scale Of Production Of Coronavirus Serology Test",2020-05-19 16:07:00-04:00,TECH,neutral
1218582.0,"Benchmark Initiates Coverage On Bio-Techne with Buy Rating, Announces Price Target of $320",2020-05-14 08:05:00-04:00,TECH,neutral
1218583.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,TECH,negative
1218584.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,TECH,neutral
1218585.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,TECH,neutral
1218586.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,TECH,negative
1218587.0,Stocks That Hit 52-Week Highs On Monday,2020-05-11 10:28:00-04:00,TECH,neutral
1218588.0,Stocks That Hit 52-Week Highs On Friday,2020-05-08 10:32:00-04:00,TECH,neutral
1218589.0,"The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda",2020-05-08 07:59:00-04:00,TECH,neutral
1218590.0,Bio-Techne Highlights Publication Of ExoDx Prostate EPI Test Study,2020-05-07 10:42:00-04:00,TECH,neutral
1218591.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-07 10:33:00-04:00,TECH,neutral
1218592.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,TECH,negative
1218593.0,Stocks That Hit 52-Week Highs On Wednesday,2020-05-06 10:43:00-04:00,TECH,neutral
1218594.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,TECH,positive
1218595.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-05 10:48:00-04:00,TECH,neutral
1218596.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,TECH,positive
1218597.0,Stocks That Hit 52-Week Highs On Monday,2020-05-04 10:35:00-04:00,TECH,neutral
1218598.0,"Stephens & Co. Maintains Overweight on Bio-Techne, Raises Price Target to $253",2020-05-01 11:43:00-04:00,TECH,negative
1218599.0,"Wells Fargo Maintains Equal-Weight on Bio-Techne, Raises Price Target to $220",2020-05-01 09:24:00-04:00,TECH,positive
1218600.0,"Stifel Maintains Buy on Bio-Techne, Raises Price Target to $245",2020-05-01 08:32:00-04:00,TECH,neutral
1218601.0,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",2020-05-01 07:54:00-04:00,TECH,neutral
1218602.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,TECH,positive
1218603.0,"Bio-Techne Q3 Adj. EPS $1.390 Beats $1.150 Estimate, Sales $194.700M Beat $185.430M Estimate",2020-04-30 06:47:00-04:00,TECH,neutral
1218604.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,TECH,negative
1218605.0,"Citigroup Maintains Neutral on Bio-Techne, Raises Price Target to $215",2020-04-20 13:35:00-04:00,TECH,neutral
1218606.0,Bio-Techne's Exosome Diagnostics Launches ExoDx Prostate At-Home Collection Kit,2020-04-15 07:04:00-04:00,TECH,neutral
1218607.0,"Stifel Maintains Buy on Bio-Techne, Lowers Price Target to $210",2020-04-02 10:51:00-04:00,TECH,negative
1218608.0,"Wells Fargo Maintains Equal-Weight on Bio-Techne, Lowers Price Target to $190",2020-03-30 10:37:00-04:00,TECH,positive
1218609.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,TECH,negative
1218610.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,TECH,negative
1218611.0,"Citigroup Maintains Neutral on Bio-Techne, Lowers Price Target to $175",2020-03-20 09:41:00-04:00,TECH,negative
1218612.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,TECH,neutral
1218613.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,TECH,neutral
1218614.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,TECH,negative
1218615.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,TECH,negative
1218616.0,Shares of several technology companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 08:46:00-05:00,TECH,neutral
1218617.0,"Shares of companies in the software, technology and semiconductor spaces are trading lower as continued coronavirus fears cause weakness across sectors.",2020-02-27 08:28:00-05:00,TECH,negative
1218618.0,"Baird Maintains Outperform on Bio-Techne, Raises Price Target to $230",2020-02-05 09:08:00-05:00,TECH,neutral
1218619.0,"Citigroup Maintains Neutral on Bio-Techne, Lowers Price Target to $225",2020-02-05 07:46:00-05:00,TECH,negative
1218620.0,Shares of basic materials companies are trading higher amid a rebound in global equities following last week's selloff on coronavirus fears.,2020-02-04 09:09:00-05:00,TECH,negative
1218621.0,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares",2020-02-04 07:51:00-05:00,TECH,negative
1218622.0,"Bio-Techne Q2 Adj. EPS $1.08 Misses $1.13 Estimate, Sales $184.934M Miss $191.24M Estimate",2020-02-04 06:43:00-05:00,TECH,negative
1218623.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,TECH,neutral
1218624.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,TECH,positive
1218625.0,"Bio-Techne, Fresenius Kabi And Wilson Wolf Form New Venture To Create Scalable Manufacturing Platforms For Cell And Gene Therapies",2020-01-21 08:41:00-05:00,TECH,positive
1218626.0,"Bio-Techne, Fresenius Kabi And Wilson Wolf Form New Venture To Create Scalable Manufacturing Platforms For Cell And Gene Therapies",2020-01-21 08:41:00-05:00,TECH,positive
1218627.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,TECH,positive
1218628.0,"Wells Fargo Initiates Coverage On Bio-Techne with Equal-Weight Rating, Announces $230 Price Target",2020-01-08 09:22:00-05:00,TECH,positive
1218629.0,Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio,2020-01-07 07:11:00-05:00,TECH,neutral
1218630.0,"Citigroup Initiates Coverage On Bio-Techne with Neutral Rating, Announces $235 Price Target",2020-01-07 07:01:00-05:00,TECH,neutral
1218631.0,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict",2019-12-24 07:24:00-05:00,TECH,negative
1218632.0,Stocks That Hit 52-Week Highs On Monday,2019-12-23 10:20:00-05:00,TECH,neutral
1218633.0,Bio-Techne's Exosome Diagnostics Lab Receives Accreditation From College Of American Pathologists,2019-12-17 07:09:00-05:00,TECH,neutral
1218634.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,TECH,negative
1218635.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-26 11:03:00-05:00,TECH,neutral
1218636.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,TECH,positive
1218637.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,TECH,positive
1218638.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,TECH,positive
1218639.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-20 10:12:00-05:00,TECH,neutral
1218640.0,"Stifel Nicolaus Initiates Coverage On Bio-Techne with Buy Rating, Announces $235 Price Target",2019-11-15 06:49:00-05:00,TECH,neutral
1218641.0,"Bio-Techne Licenses aTAG Technology From C4 Therapeutics, Inc.",2019-11-06 07:10:00-05:00,TECH,neutral
1218642.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,TECH,positive
1218643.0,"Bio-Techne Q1 Adj. EPS $1.06 Beats $1.05 Estimate, Sales $183.2M Beat $179.4M Estimate",2019-10-29 06:36:00-04:00,TECH,neutral
1218644.0,Bio-Techne to Invest $40-50M to Expand its GMP-Grade Protein Production Capacity,2019-10-28 07:14:00-04:00,TECH,positive
1218645.0,Bio-Techne Reports Medicare Issued Final Local Coverage Decision For Co.'s ExoDx Prostate Test,2019-10-10 14:26:00-04:00,TECH,neutral
1218646.0,"Bio-Techne Q4 Adj. EPS $1.25 Misses $1.33 Estimate, Sales $191.7M Miss $197.77M Estimate",2019-08-06 06:40:00-04:00,TECH,negative
1218647.0,"Bio-Techne Reports Strategic License, Supply Deal With Quanterix's Uman Diagnostics For Antibodies Used In Quantification Of Neurofilament Light On ProetinSimple-Branded Ella Platform, No Terms Disclosed",2019-07-23 09:18:00-04:00,TECH,negative
1218648.0,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",2019-07-05 08:55:00-04:00,TECH,negative
1218649.0,10 Biggest Price Target Changes For Tuesday,2019-07-02 09:49:00-04:00,TECH,neutral
1218650.0,"Benzinga's Top Upgrades, Downgrades For July 2, 2019",2019-07-02 09:13:00-04:00,TECH,positive
1218651.0,"Janney Capital Upgrades Bio-Techne to Buy, Raises Price Target to $270",2019-07-02 07:27:00-04:00,TECH,neutral
1218652.0,FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx Prostate IntelliScore) Test,2019-06-17 09:15:00-04:00,TECH,positive
1218653.0,Bio-Techne Receives Approval To Offer The ExoDx Prostate Intelliscore (EPI) Test In New York State,2019-06-13 16:36:00-04:00,TECH,positive
1218654.0,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes",2019-06-13 07:44:00-04:00,TECH,negative
1218655.0,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",2019-06-12 07:34:00-04:00,TECH,neutral
1218656.0,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",2019-06-11 07:34:00-04:00,TECH,positive
1218657.0,"The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix",2019-06-07 07:24:00-04:00,TECH,positive
1218658.0,"Bio-Techne Reports Purchase Of B-MoGen Biotech, No Terms Disclosed",2019-06-04 17:34:00-04:00,TECH,negative
1218659.0,Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostic,2019-05-28 09:24:00-04:00,TECH,neutral
1218660.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,TECH,neutral
1218661.0,Roche Highlights Expanded Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options for mRNA ISH Tissue Analysis,2019-05-06 07:27:00-04:00,TECH,neutral
1218662.0,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",2019-04-30 08:06:00-04:00,TECH,positive
1218663.0,"Bio-Techne Q3 EPS $1.21 Beats $1.14 Estimate, Sales $184.9M Beat $182.9M Estimate",2019-04-30 06:38:00-04:00,TECH,neutral
1218664.0,"Elpiscience BioPharma, Bio-Techne Report Strategic Collaboration For Development Of Anti-Cancer Therapeutics",2019-04-22 09:15:00-04:00,TECH,neutral
1218665.0,Bio-Techne And NanoString Partner To Co-Develop Integrated Workflow For RNA Spatial Profiling,2019-03-28 06:09:00-04:00,TECH,neutral
1218666.0,"Stocks Trading Ex Dividend For Thurs., Feb. 14, 2019",2019-02-14 11:29:00-05:00,TECH,neutral
1218667.0,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",2019-02-05 07:47:00-05:00,TECH,positive
1218668.0,"Bio-Techne Q2 Adj. EPS $1.06 Beats $0.98 Estimate, Sales $174.5M Beat $170.19M Estimate",2019-02-05 06:35:00-05:00,TECH,neutral
1218669.0,Bio-Techne Shares Spike Over $172 To Session High As Co. Issues Press Release Highlighting ExoDx Prostate Was Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection,2019-01-31 14:34:00-05:00,TECH,negative
1218670.0,"Barron's Picks And Pans: Barrick Gold, Costco, Disney, GE And More",2019-01-19 13:00:00-05:00,TECH,neutral
1218671.0,"Stephens & Co. Upgrades Bio-Techne to Overweight, Announces $180 Price Target",2019-01-14 08:56:00-05:00,TECH,negative
1218672.0,Bio-Techne Releases GMP ROCK Inhibitor And CHIR 99021 For Stem Cell Therapy,2018-12-04 09:16:00-05:00,TECH,negative
1218673.0,"Stocks Trading Ex Dividend For Thurs., Nov. 8, 2018",2018-11-08 10:55:00-05:00,TECH,neutral
1218674.0,8 Biggest Price Target Changes For Wednesday,2018-10-31 10:02:00-04:00,TECH,neutral
1218675.0,"Craig-Hallum Downgrades Bio-Techne to Hold, Lowers Price Target to $154",2018-10-31 08:41:00-04:00,TECH,negative
1218676.0,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",2018-10-30 08:00:00-04:00,TECH,neutral
1218677.0,"Bio-Techne Q1 EPS $0.98 Beats $0.94 Estimate, Sales $162.97M Beat $161.67M Estimate",2018-10-30 07:52:00-04:00,TECH,neutral
1218678.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,TECH,neutral
1218679.0,"Benzinga's Top Upgrades, Downgrades For October 17, 2018",2018-10-17 09:09:00-04:00,TECH,positive
1218680.0,"Goldman Sachs Initiates Coverage On Bio-Techne with Neutral Rating, Announces $190 Price Target",2018-10-17 06:14:00-04:00,TECH,neutral
1218681.0,Bio-Techne Signs Strategic Cooperation Agreement With Micropoint Bioscience,2018-10-12 08:30:00-04:00,TECH,positive
1218682.0,10 Biggest Price Target Changes For Tuesday,2018-10-02 09:48:00-04:00,TECH,neutral
1218683.0,"Argus Maintains Buy on Bio-Techne, Raises Price Target to $230",2018-10-02 07:44:00-04:00,TECH,neutral
1218684.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,TECH,neutral
1218685.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,TECH,neutral
1218686.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,TECH,positive
1218687.0,"Stocks Which Set New 52-Week High Yesterday, September 17th",2018-09-18 09:25:00-04:00,TECH,neutral
1218688.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,TECH,neutral
1218689.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,TECH,neutral
1218690.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,TECH,neutral
1218691.0,"Stocks Which Set New 52-Week High Yesterday, September 11th",2018-09-12 12:17:00-04:00,TECH,neutral
1218692.0,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet",2018-09-11 08:25:00-04:00,TECH,negative
1218693.0,"Stocks Which Set New 52-Week High Friday, September 7th",2018-09-10 16:36:00-04:00,TECH,neutral
1218694.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,TECH,neutral
1218695.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,TECH,neutral
1218696.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,TECH,neutral
1218697.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,TECH,neutral
1218698.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,TECH,neutral
1218699.0,"The Daily Biotech Pulse: Immunomedics' Bottom-Line Miss; Kala, Regeneron Await FDA Verdict",2018-08-24 08:47:00-04:00,TECH,positive
1218700.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,TECH,neutral
1218701.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,TECH,neutral
1218702.0,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",2018-08-22 08:20:00-04:00,TECH,negative
1218703.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,TECH,neutral
1218704.0,"Citigroup Maintains Buy on Bio-Techne, Raises Price Target to $205",2018-08-09 08:55:00-04:00,TECH,neutral
1218705.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,TECH,neutral
1218706.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,TECH,positive
1218707.0,77 Biggest Movers From Yesterday,2018-08-08 06:04:00-04:00,TECH,neutral
1218708.0,64 Stocks Moving In Tuesday's Mid-Day Session,2018-08-07 13:01:00-04:00,TECH,neutral
1218709.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,TECH,neutral
1218710.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,TECH,negative
1218711.0,36 Stocks Moving In Tuesday's Pre-Market Session,2018-08-07 08:04:00-04:00,TECH,neutral
1218712.0,"Bio-Techne Q4 EPS $1.34 Beats $1.29 Estimate, Sales $180.3M Beat $174.77M Estimate",2018-08-07 07:02:00-04:00,TECH,neutral
1218713.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,TECH,neutral
1218714.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,TECH,neutral
1218715.0,Deutsche Bank Downgrades Bio-Techne to Hold,2018-06-27 08:34:00-04:00,TECH,neutral
1218717.0,Bio-Techne To Acquire Exosome Diagnostics For $250M In Cash Plus Contingent Consideration Of Up To $325M Upon Achievement Of Certain Milestones,2018-06-25 16:11:00-04:00,TECH,positive
1218718.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,TECH,neutral
1218719.0,"Benzinga's Top Upgrades, Downgrades For June 15, 2018",2018-06-15 09:05:00-04:00,TECH,positive
1218720.0,"Argus Initiates Coverage On Bio-Techne with Buy Rating, Announces $185 Price Target",2018-06-15 07:48:00-04:00,TECH,neutral
1218721.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,TECH,negative
1218722.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,TECH,negative
1218723.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,TECH,positive
1218724.0,Bio-Techne To Acquire Quad Technologies; No Financial Terms Disclosed; Transaction To Be Financed Through Available Cash On Hand,2018-06-07 08:26:00-04:00,TECH,positive
1218725.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,TECH,neutral
1218726.0,"Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate",2018-06-06 08:38:00-04:00,TECH,positive
1218727.0,"Deutsche Bank Maintains Buy on Bio-Techne, Lowers Price Target to $165.00",2018-05-03 08:49:00-04:00,TECH,negative
1218728.0,"Bio-Techne Q3 EPS $1.21 Beats $1.14 Estimate, Sales $163.973M Beat $163.97M Estimate",2018-05-02 07:23:00-04:00,TECH,neutral
1218729.0,"Deutsche Bank Maintains Buy on Bio-Techne, Raises Price Target to $163.00",2018-03-01 12:08:00-05:00,TECH,neutral
1218730.0,"Baird Maintains Outperform on Bio-Techne, Raises price target to $157.00",2018-02-07 12:12:00-05:00,TECH,neutral
1218731.0,"Bio-Techne Reports Q2 Adj. EPS $1.02 vs $0.92 Est., Sales $154.2M vs $146.2M Est.",2018-02-06 07:07:00-05:00,TECH,neutral
1218732.0,"Bio-Techne Reports Purchase Of Atlanta Biologicals, No Terms Disclosed",2018-01-02 17:02:00-05:00,TECH,negative
1218733.0,"Bio-Techne Reports Q1 Adj. EPS $0.90 vs $0.88 Est., Sales $144.6M vs $142.44M Est.",2017-10-31 07:36:00-04:00,TECH,neutral
1218734.0,"Bio-Techne Reports Q4 Adj. EPS $1.09 vs $0.99 Est., Sales $156.6M vs $150.2M Est.",2017-08-08 09:32:00-04:00,TECH,neutral
1218735.0,Wells Fargo Initiates Coverage On Bio-Techne with Market Perform Rating,2017-07-13 07:38:00-04:00,TECH,positive
1218736.0,"Bio-Techne Reports Q3 Adj. EPS $0.97 vs $0.93 Est., Sales $144M vs $142.7M Est.",2017-05-02 07:42:00-04:00,TECH,neutral
1218737.0,Janney Capital Downgrades Bio-Techne To Neutral,2017-03-27 07:22:00-04:00,TECH,neutral
1218738.0,Bio-Techne Signs Exclusive License Agreement With Multiclonal Therapeutics For 'Ground-State' Stem Cell Tech,2017-03-07 08:33:00-05:00,TECH,positive
1218739.0,"Benzinga's Top Upgrades, Downgrades For February 9, 2017",2017-02-09 09:48:00-05:00,TECH,positive
1218740.0,"Citigroup Initiates Coverage On Bio-Techne At Buy, Announces $115 Price Target",2017-02-09 07:03:00-05:00,TECH,neutral
1218741.0,"Bio-Techne Reports 2 EPS $0.81 vs. Est. $0.85, Rev. $131.8M vs. Est. $134.5M",2017-02-07 07:32:00-05:00,TECH,neutral
1218742.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,TECH,positive
1218743.0,"Deutsche Bank Initiates Coverage On Bio-Techne At Buy, Announces Price Target Of $115",2017-01-18 08:10:00-05:00,TECH,neutral
1218744.0,Leerink Swann Assumes Bio-Techne Corp - Common Stock at Outperform,2016-11-10 09:36:00-05:00,TECH,neutral
1218745.0,"Bio-Techne Reports Q1 EPS $0.84 vs. Est. $0.79, Rev. $130.6M vs. Est. $127.4M",2016-10-31 08:01:00-04:00,TECH,neutral
1218746.0,"7 Notable Stocks Trading Ex-Dividend Thursday, August 25",2016-08-24 13:53:00-04:00,TECH,neutral
1218747.0,"Bio-Techne Reports Q4 EPS Adj. EPS $0.92 vs. Est .$0.96, Rev. $134.8M vs. Est. $129.2M",2016-08-17 07:02:00-04:00,TECH,neutral
1218748.0,"Earnings Scheduled For August 17, 2016",2016-08-17 04:16:00-04:00,TECH,neutral
1218749.0,"Bio-Techne to Acquire Advanced Cell Diagnostics for $250M in Cash, $75M in Contingent Consideration",2016-07-06 17:57:00-04:00,TECH,positive
1218750.0,Bio-Techne Gets Access To B-MoGen Biotechnologies' Gene Editing Technology,2016-05-04 06:40:00-04:00,TECH,neutral
1218751.0,Bio-Techne Announces Access to B-MoGen Biotechnologies' Gene Editing Technology,2016-05-04 06:20:00-04:00,TECH,neutral
1218752.0,Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology,2016-05-04 06:04:00-04:00,TECH,neutral
1218753.0,Janney Capital Upgrades Bio-Techne to Buy,2016-05-03 11:52:00-04:00,TECH,neutral
1218754.0,"Bio-Techne Reports Q3 EPS $1.01 vs. Est. $0.89, Rev. $131M vs Est. $122.6M",2016-05-03 07:09:00-04:00,TECH,neutral
1218755.0,"Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, no terms",2016-03-21 10:35:00-04:00,TECH,negative
1218756.0,"Bio-Techne Reports Q2 Adj. EPS $0.88 vs $0.82 Est., Sales $120.9M vs $118.6M Est.",2016-02-02 07:21:00-05:00,TECH,neutral
1218757.0,Stephens & Co. Downgraded Bio-Techne to Equal-weight,2015-10-29 10:26:00-04:00,TECH,neutral
1218758.0,"Bio-Techne Corp Reports Q1 Adj EPS $0.79 Vs Est $0.85, Sales $112.4M Vs Est $116.43M",2015-10-28 07:06:00-04:00,TECH,neutral
1218759.0,Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership,2015-10-20 08:32:00-04:00,TECH,positive
1218760.0,"Bio-Techne Reports Q4 Adj EPS $0.87 Vs Est $0.86, Sales $117.7M vs Est $116.85M",2015-08-06 07:10:00-04:00,TECH,neutral
1218761.0,Bio-Techne Corporation Agrees to Acquire Cliniqa Corporation,2015-06-05 09:15:00-04:00,TECH,positive
1218762.0,"Bio-Techne Corp Reports Q2 Adj. EPS $0.82 Vs Est $0.86, Revs $111.9M Vs Est $113.25M",2015-02-03 06:04:00-05:00,TECH,neutral
1218763.0,Bio-Techne Announces Agreement To Acquire CyVek For $60M,2014-11-04 07:04:00-05:00,TECH,positive
1218764.0,Techne Corporation Reports Q1 EPS of $0.85 vs $0.87 Est; Revenue of $108.50M vs $108.65M Est,2014-10-28 06:04:00-04:00,TECH,neutral
1218765.0,Techne Corporation Reports Q4 EPS of $0.88 vs $0.85 Est; Revenue of $92.50M vs $91.80M Est,2014-08-11 07:00:00-04:00,TECH,neutral
1218766.0,"Earnings Scheduled For August 11, 2014",2014-08-11 05:30:00-04:00,TECH,neutral
1218767.0,Exclusive: Bio-Techne's Frank Mortari Talks 2 New Acquisitions,2014-07-30 09:14:00-04:00,TECH,positive
1218768.0,Exclusive: Bio-Techne Executive On M&A Possiblities,2014-07-16 10:59:00-04:00,TECH,positive
1218769.0,Bio-Techne Director of BD on Possible Acquirers at Current Market Value - BenzingaPro Exclusive,2014-07-15 15:42:00-04:00,TECH,positive
1218770.0,Bio-Techne Director of BD on Acquisition Possibilities - BenzingaPro Exclusive,2014-07-15 15:40:00-04:00,TECH,positive
1218771.0,"Benzinga's M&A Chatter for Wednesday July 2, 2014",2014-07-02 18:01:00-04:00,TECH,neutral
1218772.0,Bio-Techne Announces Agreement To Acquire Novus Biologicals For $60M,2014-07-02 16:15:00-04:00,TECH,positive
1218773.0,Bio-Techne To Acquire ProteinSimple For ~$300M,2014-06-17 07:18:00-04:00,TECH,neutral
1218774.0,Techne Corporation Reports Q3 EPS of $0.94 vs $0.89 Est; Revenue of $96.50M vs $92.50M Est,2014-04-28 07:09:00-04:00,TECH,neutral
1218775.0,Bio-Techne Announces Acquisition Agreement,2014-04-15 08:01:00-04:00,TECH,positive
1218776.0,Bio-Techne Announces $10M Investment in Cyvek,2014-04-04 07:09:00-04:00,TECH,neutral
1218777.0,An Investor's Guide to Hot In Vitro Diagnostics Market,2014-02-12 11:04:00-05:00,TECH,neutral
1218778.0,Techne Corporation Reports Q1 EPS of $0.74; Revenue of $85.70M,2013-10-29 07:01:00-04:00,TECH,neutral
1218779.0,"Techne Corp Shares Jump Nearly 4% as Baird Upgraded to Outperform, Raised Price Target to $90",2013-09-20 11:47:00-04:00,TECH,positive
1218780.0,"Craig-Hallum Upgrades Techne Corporation to Buy, Raises PT to $85.00",2013-08-07 09:49:00-04:00,TECH,neutral
1218781.0,Techne Corporation Appoints Dr. J. Fernando Bazan As Chief Technology Officer ,2013-07-23 07:17:00-04:00,TECH,neutral
1218782.0,Techne to Acquire Bionostics Holdings,2013-06-18 07:03:00-04:00,TECH,neutral
1218783.0,Techne Corporation Reports Q1 EPS of $0.88 vs $0.90 Est; Revenue of $81.0M vs $84.0M Est,2013-04-30 07:11:00-04:00,TECH,neutral
1218784.0,Techne Corporation Reports Q2 EPS of $0.74 vs $0.77 Est; Revenue of $75.10M vs $76.40M Est,2013-02-05 07:13:00-05:00,TECH,neutral
1218785.0,Techne Increases Share Repurchase Program,2012-10-25 16:07:00-04:00,TECH,positive
1218786.0,From Earlier: Techne Reports Q1 EPS $0.75 vs $0.79 Est,2012-10-23 13:23:00-04:00,TECH,neutral
1218787.0,Techne Reports Q4 EPS $0.80 vs $0.85 Est; Revenues $78.7M vs $80.40M Est,2012-07-31 07:23:00-04:00,TECH,neutral
1218788.0,5 Healthcare Stocks With The Highest Operating Margin,2012-06-18 07:25:00-04:00,TECH,neutral
1218789.0,Top 4 Mid-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Operating Margin,2012-04-26 03:12:00-04:00,TECH,positive
1218790.0,Techne Reports Q2 EPS $0.70 vs $0.79 Est; Revenues $74.70M vs $76.52M Est	 				,2012-01-31 07:04:00-05:00,TECH,neutral
1218791.0,Eight Healthcare Stocks Insiders Are Bullish About,2011-12-27 15:04:00-05:00,TECH,neutral
1218792.0,Techne Reports Q1 EPS $0.74 vs $0.84 Est; Revenues $77.6M vs $78.66M Est				,2011-10-25 07:04:00-04:00,TECH,neutral
1218793.0,Techne Announces Quarterly Dividend of $0.27/Share,2011-08-02 07:26:00-04:00,TECH,neutral
1218794.0,Techne Reports Q4 EPS $0.85 vs $0.77 Est,2011-08-02 07:25:00-04:00,TECH,neutral
1218795.0,Stocks to Watch for 6/29/11: Fresh 52 Week Highs and Lows,2011-06-29 04:11:00-04:00,TECH,positive
1218796.0,"NASDAQ Stocks Hitting 52-Week Highs (LONG, TECH, ANTH, TSTF)",2011-05-17 10:08:00-04:00,TECH,neutral
1218797.0,Techne Corporation Announces Acquisition (TECH),2011-05-03 07:43:00-04:00,TECH,neutral
1218798.0,Techne Corp Reports EPS of $0.84 vs. $0.80 Estimate; Revenues $76.3M vs. $73.73M Estimate (TECH),2011-05-03 07:42:00-04:00,TECH,neutral
1218799.0,Techne Corporation Releases Third Quarter Results for Fiscal Year 2011 ,2011-05-03 06:56:00-04:00,TECH,neutral
1218800.0,"Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (TECH, CEPH, ILMN, TLCR)",2011-02-18 03:08:00-05:00,TECH,positive
1218801.0,Bearish MACD for Techne Corp - Tale of the Tape,2010-11-09 10:33:00-05:00,TECH,neutral
1218802.0,Techne Corporation Declares Dividend of $0.27,2010-10-28 16:06:00-04:00,TECH,neutral
1218803.0,Life Sciences Research From Jefferies,2010-09-27 08:52:00-04:00,TECH,neutral
1218804.0,PAO ACUCAR-GDR (CBD) - Profit Tracks,2010-09-14 19:11:00-04:00,TECH,positive
1218805.0,"Zacks Sell List Highlights: Amazon.com, Companhia Brasileira de Distrib, Techne and Landauer    - Press Releases",2010-09-14 19:10:00-04:00,TECH,neutral
1218806.0,"Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest ROE (GILD, TLCR, TECH, AMGN)",2010-09-09 07:13:00-04:00,TECH,positive
1218807.0,"Top 5 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margins (QLTI, PDLI, TECH, GILD, AMGN)",2010-06-03 07:43:00-04:00,TECH,positive
1218808.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,TECH,positive
1218809.0,Report criticizes Yahoo (YHOO) over prescription-drug ads,2009-08-21 10:47:00-04:00,TECH,negative
1218810.0,Winland Online Shipping Reports 2009 Second Quarter Results Continued to Be Impacted by Depressed Global Shipping Market,2009-08-17 09:31:00-04:00,TECH,negative
1218811.0,"Forbes Medi-Tech Announces Financial Results for Second Quarter Ended June 30, 2009",2009-08-13 16:15:00-04:00,TECH,neutral
